The role of genetic diversity, epigenetic regulation, and sex-based differences in HIV cure research: a comprehensive review
Abstract Despite significant advances in HIV treatment, a definitive cure remains elusive. The first-in-human clinical trial of Excision BioTherapeutics’ CRISPR-based HIV cure, EBT-101, demonstrated safety but failed to prevent viral rebound. These outcomes may result from the interplay of several f...
Saved in:
Main Authors: | Punitha Letchumanan, Kumitaa Theva Das |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2025-01-01
|
Series: | Epigenetics & Chromatin |
Subjects: | |
Online Access: | https://doi.org/10.1186/s13072-024-00564-4 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Mechanisms and technologies in cancer epigenetics
by: Zaki A. Sherif, et al.
Published: (2025-01-01) -
Editorial: Current insights in Epigenetics and Epigenomics
by: Steven Henikoff, et al.
Published: (2025-02-01) -
Editorial: Epigenetics and genomic causality in development and chromatin research
by: Ellen V. Rothenberg, et al.
Published: (2025-02-01) -
Sex differences in epigenetic ageing for older people living with HIVResearch in context
by: Carrie D. Johnston, et al.
Published: (2025-03-01) -
Building the Frequency Profile of the Core Promoter Element Patterns in the Three ChromHMM Promoter States at 200bp Intervals: A Statistical Perspective
by: Heather Lent, et al.
Published: (2015-12-01)